AdaptHealth Corp. (NASDAQ:AHCO) Shares Bought by Geode Capital Management LLC

Geode Capital Management LLC grew its position in AdaptHealth Corp. (NASDAQ:AHCO) by 12.2% during the 3rd quarter, Holdings Channel reports. The fund owned 2,451,173 shares of the company’s stock after buying an additional 265,712 shares during the quarter. Geode Capital Management LLC’s holdings in AdaptHealth were worth $27,532,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Reinhart Partners LLC. raised its position in AdaptHealth by 45.2% during the third quarter. Reinhart Partners LLC. now owns 6,198,642 shares of the company’s stock worth $69,611,000 after acquiring an additional 1,929,339 shares during the last quarter. Divisadero Street Capital Management LP lifted its position in AdaptHealth by 179.7% during the second quarter. Divisadero Street Capital Management LP now owns 1,161,592 shares of the company’s stock valued at $11,616,000 after buying an additional 746,340 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in AdaptHealth by 43.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 2,327,738 shares of the company’s stock worth $23,277,000 after buying an additional 710,131 shares during the period. State Street Corp increased its position in shares of AdaptHealth by 19.8% during the third quarter. State Street Corp now owns 4,124,284 shares of the company’s stock worth $46,316,000 after acquiring an additional 681,816 shares during the last quarter. Finally, FMR LLC lifted its stake in shares of AdaptHealth by 9.3% in the third quarter. FMR LLC now owns 7,350,549 shares of the company’s stock worth $82,547,000 after acquiring an additional 624,645 shares in the last quarter. Institutional investors and hedge funds own 82.67% of the company’s stock.

AdaptHealth Trading Down 2.6 %

NASDAQ AHCO opened at $9.79 on Friday. The firm’s 50 day moving average price is $10.07 and its two-hundred day moving average price is $10.43. The stock has a market cap of $1.32 billion, a price-to-earnings ratio of -5.93, a PEG ratio of 1.36 and a beta of 1.10. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. AdaptHealth Corp. has a twelve month low of $6.46 and a twelve month high of $11.90.

AdaptHealth (NASDAQ:AHCO) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $0.15 EPS for the quarter, missing the consensus estimate of $0.17 by ($0.02). The company had revenue of $805.90 million for the quarter, compared to analyst estimates of $809.32 million. AdaptHealth had a positive return on equity of 9.62% and a negative net margin of 6.57%. The business’s revenue for the quarter was up .2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.19 earnings per share. Equities analysts anticipate that AdaptHealth Corp. will post 0.88 EPS for the current year.

Wall Street Analysts Forecast Growth

AHCO has been the topic of a number of recent analyst reports. Truist Financial cut their target price on AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a research report on Friday, November 15th. Canaccord Genuity Group reduced their price objective on shares of AdaptHealth from $14.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, November 6th. Royal Bank of Canada dropped their target price on shares of AdaptHealth from $13.00 to $11.00 and set an “outperform” rating for the company in a research report on Tuesday, November 19th. Robert W. Baird reduced their price target on shares of AdaptHealth from $16.00 to $14.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 6th. Finally, UBS Group lowered their target price on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating for the company in a research note on Wednesday, November 6th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, AdaptHealth currently has a consensus rating of “Moderate Buy” and an average target price of $11.67.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.